Overview

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Status:
RECRUITING

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

Study of safety, tolerability and pharmacokinetic parameters of different doses of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) in healthy volunteers

Phase:

PHASE1

Details

Lead Sponsor:

Valenta Pharm JSC